Plain-English translation of NCT06642831 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are looking for new blood markers — measurable signs in your blood — that could help doctors more reliably diagnose polycystic ovarian syndrome (PCOS) in teenage and young adult women. This study compares blood samples and health information from women with PCOS to those without it, to identify which markers are most helpful for diagnosis. If you're diagnosed with PCOS during the study, you'll have follow-up visits to see how you're doing on treatment.
PCOS affects many young women but can be tricky to diagnose reliably. By finding specific blood markers that clearly show whether someone has the condition, doctors could catch and treat it faster, helping young women get the care they need sooner.
You likely qualify if…
You likely don't qualify if…
You'll start with one visit where a doctor will ask about your health history and do an ultrasound, and you'll have blood drawn. If you're diagnosed with PCOS, you'll return for two more visits — one at 3 months and another at 6 to 12 months later — where doctors will check on how treatment is working and collect more blood samples. The whole process takes place over several months, with each visit lasting an hour or so.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
Germany
Collaborators
Roche Diagnostics International AG
Enrollment target
~380 participants
Started
January 2023
Primary completion
December 2026
Age range
15 Years – 25 Years
Sex
Female only
Last updated on clinicaltrials.gov in October 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Laura Lotz, Dr. med.
University Hospital Erlangen
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.